btm 1042 has been researched along with 4-diphenylacetoxy-1,1-dimethylpiperidinium in 1 studies
| Studies (btm 1042) | Trials (btm 1042) | Recent Studies (post-2010) (btm 1042) | Studies (4-diphenylacetoxy-1,1-dimethylpiperidinium) | Trials (4-diphenylacetoxy-1,1-dimethylpiperidinium) | Recent Studies (post-2010) (4-diphenylacetoxy-1,1-dimethylpiperidinium) |
|---|---|---|---|---|---|
| 11 | 0 | 0 | 446 | 1 | 52 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, E; Boer, R; Eltze, M; Kromer, W | 1 |
1 other study(ies) available for btm 1042 and 4-diphenylacetoxy-1,1-dimethylpiperidinium
| Article | Year |
|---|---|
Telenzepine inhibits electrically-stimulated, acetylcholine plus histamine-mediated acid secretion in the mouse isolated stomach by blockade of M1 muscarine receptors.
Topics: Acetylcholine; Alkaloids; Animals; Anti-Ulcer Agents; Electric Stimulation; Furans; Gastric Acid; Gastric Mucosa; Histamine; Mice; Muscarinic Antagonists; Naphthalenes; p-Methoxy-N-methylphenethylamine; Parasympatholytics; Piperidines; Pirenzepine; Stomach; Thiazepines; Vagus Nerve | 1991 |